In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trametinib Dimethyl Sulfoxide Drug Master File in Korea (Trametinib Dimethyl Sulfoxide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trametinib Dimethyl Sulfoxide. The MFDS reviews the Trametinib Dimethyl Sulfoxide KDMF as part of the drug registration process and uses the information provided in the Trametinib Dimethyl Sulfoxide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trametinib Dimethyl Sulfoxide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trametinib Dimethyl Sulfoxide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trametinib Dimethyl Sulfoxide suppliers with KDMF on PharmaCompass.